Novel B cell depleters! Bispecific T cell engagers (BiTEs) being studied for
#SLE &
#RA as a way to get CAR-T cell like responses but more accessible w/less risk for CK release syndrome.
#EULAR24
T cell-engaging therapies — BiTEs and beyond | Nature Reviews Clinical Oncology